Showing results (81-90 of 94) with videos related to
Sort By:
Pageof 10
Cancer Cell|November 23, 2023
Therapeutic targeting of EP300/CBP by bromodomain inhibition in hematologic malignanciesLuciano Nicosia, Gary J Spencer, Nigel Brooks, et al.Blood Advances|May 17, 2024
The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblastsIn Young Choi, Jonathan P Ling, Jian Zhang, et al.Journal of Medicinal Chemistry|December 23, 2016
Discovery and Optimization of Allosteric Inhibitors of Mutant Isocitrate Dehydrogenase 1 (R132H IDH1) Displaying Activity in Human Acute Myeloid Leukemia CellsStuart Jones, Jonathan Ahmet, Kelly Ayton, et al.Leukemia|October 4, 2024
Synergistic effect of concurrent high molecular risk mutations and lower JAK2 mutant variant allele frequencies on prognosis in patients with myelofibrosis-insights from a multicenter studyYu-Hung Wang, Chao-Hung Wei, Chien-Chin Lin, et al.Nature|October 4, 2019
Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesisAkihide Yoshimi, Kuan-Ting Lin, Daniel H Wiseman, et al.Cell Stem Cell|August 15, 2023
Single-cell multi-omics defines the cell-type-specific impact of splicing aberrations in human hematopoietic clonal outgrowthsMariela Cortés-López, Paulina Chamely, Allegra G Hawkins, et al.American Journal of Human Genetics|July 24, 2004
A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD StudyElizabeth R Hauser, David C Crossman, Christopher B Granger, et al.BMC Cancer|September 24, 2022
The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromesTamara K Moyo, Jason H Mendler, Raphael Itzykson, et al.The Lancet. Haematology|June 4, 2026
Donor cell-derived haematological neoplasms after allogeneic haematopoietic cell transplantation: recommendations from the EBMT Practice Harmonisation and Guidelines CommitteeCarmelo Gurnari, Chris Armstrong, Giorgia Battipaglia, et al.Blood|July 29, 2024
Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletionMaria Julia Montoro, Laura Palomo, Claudia Haferlach, et al.Pageof 10